Literature DB >> 3873068

B-cell growth factor (B-cell growth factor I or B-cell-stimulating factor, provisional 1) is a differentiation factor for resting B cells and may not induce cell growth.

K Oliver, R J Noelle, J W Uhr, P H Krammer, E S Vitetta.   

Abstract

B-cell growth factor I [BCGF I or B-cell-stimulating factor, provisional 1 (BSFp1)] has been defined as a T-cell-derived lymphokine that acts as a co-stimulator of polyclonal B-cell growth in B cells cultured with anti-mu, anti-delta, or anti-Ig. Based on a number of studies it has been suggested that anti-Ig induces cell enlargement, entry into the G1 phase of the cell cycle, and expression of receptors for BSFp1. BSFp1 then induces entry of the cells into S phase. By adding BSFp1 prior to anti-Ig, we have found evidence that BSFp1 renders cells susceptible to anti-Ig-mediated entry of cells into G2/S phase. In contrast, if cells are first treated with anti-Ig, washed, and then cultured with BSFp1, they do not enter S phase. Taken together, these results suggest that BSFp1 acts on the resting B cells not as a growth factor but rather as a lymphokine that prepares cells for anti-Ig-mediated activation. Taken together with previous reports that BSFp1 induces increased expression of Ia antigens on resting B cells, these studies suggest that BSFp1 may be a differentiation factor rather than a growth factor and that it acts on resting B cells.

Mesh:

Substances:

Year:  1985        PMID: 3873068      PMCID: PMC397579          DOI: 10.1073/pnas.82.8.2465

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Requirements for mitogenic stimulation of murine B cells by soluble anti-IgM antibodies.

Authors:  C L Sidman; E R Unanue
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

2.  Relationship between RNA content and progression of lymphocytes through S phase of cell cycle.

Authors:  Z Darzynkiewicz; D Evenson; L Staiano-Coico; T Sharpless; M R Melamed
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

Review 3.  Role of H-2 gene products in the function of T helper cells from normal and chimeric mice in vivo.

Authors:  J Sprent
Journal:  Immunol Rev       Date:  1978       Impact factor: 12.988

4.  Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

Authors:  M Howard; J Farrar; M Hilfiker; B Johnson; K Takatsu; T Hamaoka; W E Paul
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

5.  Monoclonal antibodies against HLA-DR antigens replace T helper cells in activation of B lymphocytes.

Authors:  R Palacios; O Martinez-Maza; K Guy
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

6.  Internalized membrane immunoglobulin meets intracytoplasmic DR antigen in human B lymphoblastoid cells.

Authors:  M Pletscher; B Pernis
Journal:  Eur J Immunol       Date:  1983-07       Impact factor: 5.532

7.  T cell-derived B cell growth and differentiation factors. Dichotomy between the responsiveness of B cells from adult and neonatal mice.

Authors:  E Pure; P C Isakson; J W Kappler; P Marrack; P H Krammer; E S Vitetta
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

8.  Role of interleukin 1 in anti-immunoglobulin-induced B cell proliferation.

Authors:  M Howard; S B Mizel; L Lachman; J Ansel; B Johnson; W E Paul
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

9.  B cell growth factors and B cell differentiation factor from human T hybridomas. Two distinct kinds of B cell growth factor and their synergism in B cell proliferation.

Authors:  M Okada; N Sakaguchi; N Yoshimura; H Hara; K Shimizu; N Yoshida; K Yoshizaki; S Kishimoto; Y Yamamura; T Kishimoto
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

10.  B cell helper factors. I. Requirement for both interleukin 2 and another 40,000 mol wt factor.

Authors:  H J Leibson; P Marrack; J W Kappler
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  43 in total

Review 1.  Cell cycle control mechanisms in B-1 and B-2 lymphoid subsets.

Authors:  Michael J Piatelli; Debra Tanguay; Thomas L Rothstein; Thomas C Chiles
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  Targeting of T-B interaction using heteroconjugate antibody.

Authors:  J L Davignon; M Vallin-Davignon; P L Cohen; R A Eisenberg
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

3.  T-cell and mast cell lines respond to B-cell stimulatory factor 1.

Authors:  T R Mosmann; M W Bond; R L Coffman; J Ohara; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

Review 4.  Molecular mechanism and function of CD40/CD40L engagement in the immune system.

Authors:  Raul Elgueta; Micah J Benson; Victor C de Vries; Anna Wasiuk; Yanxia Guo; Randolph J Noelle
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

5.  Activation of immunoglobulin control elements in transgenic mice.

Authors:  A E Miller; D L Ennist; K Ozato; H Westphal
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

6.  Proliferative responsiveness of B cells from autoimmune NZB mice to anti-immunoglobulin and interleukin-4.

Authors:  M Hatakeyama; N Minato; S Kano
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

7.  B cell hyperactivity in autoimmune continuous B cell lines.

Authors:  M Aldo-Benson; M S Brooks; L Scheiderer-Pratt
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

8.  Increased expression of surface IgM but not IgD or IgG on human B cells in response to IL-4.

Authors:  J G Shields; R J Armitage; B N Jamieson; P C Beverley; R E Callard
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

9.  Cross-linking of interleukin 4 to surface molecules on murine T and B lymphocytes.

Authors:  R Fernandez-Botran; J W Uhr; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

10.  A novel Lyn-protein kinase Cδ/ε-protein kinase D axis is activated in B cells by signalosome-independent alternate pathway BCR signaling.

Authors:  Benchang Guo; Thomas L Rothstein
Journal:  Eur J Immunol       Date:  2013-04-12       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.